Product Information
CODEINE SULFATE 60 MG TABLET is a generic product labeled by Hikma Pharmaceuticals USA Inc., priced at $1.2800 per EA under NDC 00054024525. Its NADAC has been published 455 times since Nov 28, 2013.
FDA first approved this application on Jul 16, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
60 mg/1
Manufacturer
Hikma Pharmaceuticals USA Inc.NDC
00054024525
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CODEINE SULFATEApproval Type
New Drug (NDA)
FDA Application
NDA022402FDA Approved
7/16/2009
TE Code
AB
On Market Since
7/16/2009
Pharmacological Classes
Price Statistics
The NADAC for CODEINE SULFATE 60 MG TABLET has been published 455 times since Nov 28, 2013, and over the history we have for it it has risen 100.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.2800 per EA |
|---|---|
| All-time high | $1.2800 (Sep 30, 2026) |
| All-time low | $0.6176 (Jan 22, 2014) |
| 52-week high | $1.2800 |
| 52-week low | $1.0416 |
| Median price | $0.9557 |
| Average price | $0.8813 |
| Largest weekly change | +59.4% (Dec 19, 2018) |
| Weeks tracked | 455 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the codeine sulfate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Hikma Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
codeine sulfate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CODEINE SULFATE 60 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CODEINE SULFATE 60 MG TABLET, manufactured by Hikma Pharmaceuticals USA Inc., is $1.2800 per EA (NDC 00054024525), effective Sep 30, 2026.
How has the price of CODEINE SULFATE 60 MG TABLET changed over time?
Over the history we have for it, the NADAC for CODEINE SULFATE 60 MG TABLET has risen 100.6%. It has been tracked across 455 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CODEINE SULFATE 60 MG TABLET?
Since Nov 28, 2013, the NADAC for CODEINE SULFATE 60 MG TABLET has ranged from a low of $0.6176 (Jan 22, 2014) to a high of $1.2800 (Sep 30, 2026), with a median of $0.9557 per EA.
Are there cheaper alternatives to CODEINE SULFATE 60 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of CODEINE SULFATE 60 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CODEINE SULFATE 60 MG TABLET?
CODEINE SULFATE 60 MG TABLET (NDC 00054024525) is labeled by Hikma Pharmaceuticals USA Inc., and CMS classifies it as a generic product.